Main Content

“2020health is an important and thoughtful contributor to the health debate”

Dr Sarah Wollaston MP, Chairman, Health Select Committee


Call to Interview HIV

We have been drawing on literature to understand how HIV is strategically planned and managed in the UK today but we are aware that we need to go further and understand current issues. To help us explore these we would like to talk to people who are professional experts in this field.

We’d like to explore issues of how HIV is strategically planned for and managed in the UK today focusing on:

  • Gaining a better understanding of the increased costs as numbers of people living with HIV rise;
  • Redesigning services for an ageing population;
  • Exploring new settings and appropriate for managing care given advances in technology, the commitment to give patients choice as to where and when they are treated and the care they receive;
  • Developing new insights and proposals for managing co-morbidities and complex patient requirements;
  • Understanding fully the impact of the new structure for public health and treatment and care services, and how these are joined up (including mental health support services) and make recommendations on leverage to gain the best outcomes;
  • Re-evaluating and reinvigorating public health initiatives.

If this is your area of expertise, whether as clinician, commissioner, academic, patient or other please do get in touch with Sean Summers before the 1st August 2013.

2020health is conducting this research on behalf of the pharmaceutical company Gilead. The project will be undertaken in a consultancy capacity. It is fully intended that the report will reflect an independent and balanced view of the issues at stake. Gilead will participate via representation on the steering group, with the intention that the input of the steering group and other expert contributors will help develop a balanced and more independent understanding of the subject of the report to inform its research and conclusions.